Efficacy and Safety of Different Dosages of Praziquantel for the Treatment of Schistosoma Japonicum: A Systematic Review and Meta-Analysis

BACKGROUND: Praziquantel, an antischistosomal compound, is used as first-line drug for chemotherapy of Schistosoma japonicum since 1984. In this article, we conducted a systematic review and mete-analysis to evaluate the efficacy and safety of different dosages of praziquantel (PZQ) for treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Damin, Zhang, Si, Wu, Julong, Wang, Xun, Wang, Meng, Lu, Xiaoling, Chen, Huiyu, Wang, Qian, Ma, Xingming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270676/
https://www.ncbi.nlm.nih.gov/pubmed/25558390
http://dx.doi.org/10.5812/ircmj.9600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270676/
https://www.ncbi.nlm.nih.gov/pubmed/25558390
http://dx.doi.org/10.5812/ircmj.9600

Ejemplares similares